MA38847B2 - Formulation médicamenteuse à libération retardée - Google Patents
Formulation médicamenteuse à libération retardéeInfo
- Publication number
- MA38847B2 MA38847B2 MA38847A MA38847A MA38847B2 MA 38847 B2 MA38847 B2 MA 38847B2 MA 38847 A MA38847 A MA 38847A MA 38847 A MA38847 A MA 38847A MA 38847 B2 MA38847 B2 MA 38847B2
- Authority
- MA
- Morocco
- Prior art keywords
- polymeric substance
- soluble polymeric
- delayed
- release
- inner layer
- Prior art date
Links
- 230000003111 delayed effect Effects 0.000 title abstract 4
- 239000013583 drug formulation Substances 0.000 title 1
- 239000000126 substance Substances 0.000 abstract 4
- 239000011248 coating agent Substances 0.000 abstract 3
- 238000000576 coating method Methods 0.000 abstract 3
- 229920000642 polymer Polymers 0.000 abstract 3
- 210000001072 colon Anatomy 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000012530 fluid Substances 0.000 abstract 2
- 230000000968 intestinal effect Effects 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 239000006172 buffering agent Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/005—Coating of tablets or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2013/072648 WO2015062640A1 (en) | 2013-10-29 | 2013-10-29 | A delayed release drug formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA38847A1 MA38847A1 (fr) | 2017-08-31 |
| MA38847B2 true MA38847B2 (fr) | 2021-02-26 |
Family
ID=49515360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA38847A MA38847B2 (fr) | 2013-10-29 | 2013-10-29 | Formulation médicamenteuse à libération retardée |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US10799515B2 (OSRAM) |
| EP (2) | EP3542791A1 (OSRAM) |
| JP (1) | JP6273356B2 (OSRAM) |
| KR (2) | KR102174942B1 (OSRAM) |
| CN (2) | CN105555260B (OSRAM) |
| AU (2) | AU2013404367B2 (OSRAM) |
| BR (2) | BR122020013726B1 (OSRAM) |
| CA (1) | CA2923063C (OSRAM) |
| CR (1) | CR20160192A (OSRAM) |
| CU (1) | CU20160055A7 (OSRAM) |
| EA (1) | EA032504B1 (OSRAM) |
| HK (1) | HK1222547A1 (OSRAM) |
| IL (2) | IL244260B (OSRAM) |
| MA (1) | MA38847B2 (OSRAM) |
| MX (2) | MX388063B (OSRAM) |
| MY (1) | MY189394A (OSRAM) |
| NZ (2) | NZ747731A (OSRAM) |
| PH (2) | PH12020551522A1 (OSRAM) |
| SA (2) | SA116370660B1 (OSRAM) |
| SG (1) | SG11201600501UA (OSRAM) |
| TN (1) | TN2016000119A1 (OSRAM) |
| TW (3) | TWI736031B (OSRAM) |
| UA (1) | UA117260C2 (OSRAM) |
| WO (1) | WO2015062640A1 (OSRAM) |
| ZA (1) | ZA201600630B (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20200144A1 (ar) | 2012-04-30 | 2017-06-16 | Tillotts Pharma Ag | تركيبة عقار ذو إطلاق متأخر |
| CN113061089A (zh) | 2015-09-23 | 2021-07-02 | 凯瑞康宁生物工程（武汉）有限公司 | γ-羟基丁酸的前药及其组合物和用途 |
| EP3162362A1 (de) | 2015-10-30 | 2017-05-03 | Dr. Falk Pharma Gmbh | Optimierte mesalazinhaltige hochdosistablette |
| EP3257501A1 (en) | 2016-06-14 | 2017-12-20 | Tillotts Pharma AG | Multiple unit dosage form comprising a core with individual core units covered by a mucoadhesive material, and an enteric core coating |
| US20190193928A1 (en) * | 2017-12-21 | 2019-06-27 | Pepsico, Inc. | Multi-ingredient ephemeral beverage pod for making a beverage |
| EP3662898A1 (en) * | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | Solid composition comprising mesalazine |
| EP3662902B1 (en) * | 2018-12-07 | 2024-07-31 | Tillotts Pharma AG | Colonic drug delivery formulation |
| EP3662895A1 (en) | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | A process for manufacturing reducing sugar-free 5-asa tablet cores |
| EP3662901B1 (en) | 2018-12-07 | 2025-01-01 | Tillotts Pharma AG | Delayed release drug formulation comprising an outerlayer with an enzymatically degradable polymer, its composition and its method of manufacturing |
| EP3662900A1 (en) * | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | Colonic drug delivery formulation |
| GB201906917D0 (en) * | 2019-05-16 | 2019-07-03 | Intract Pharma Ltd | Novel compositions |
| JP7624444B2 (ja) * | 2019-12-11 | 2025-01-30 | エボニック オペレーションズ ゲーエムベーハー | 病気の治療又は予防において使用するための剤形 |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8812490D0 (en) | 1988-05-26 | 1988-06-29 | Agricultural & Food Res | Delayed release formulations |
| GB8819110D0 (en) | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| IT1230576B (it) * | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
| SE8903914D0 (sv) | 1989-11-22 | 1989-11-22 | Draco Ab | Oral composition for the treatment of inflammatory bowel diseases |
| GB8926639D0 (en) | 1989-11-24 | 1990-01-17 | Agricultural & Food Res | Delayed release formulations |
| US5422121A (en) | 1990-11-14 | 1995-06-06 | Rohm Gmbh | Oral dosage unit form |
| US5914132A (en) * | 1993-02-26 | 1999-06-22 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| US5656290A (en) | 1993-02-26 | 1997-08-12 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
| FR2711525B1 (fr) * | 1993-10-29 | 1996-01-12 | Virbac Laboratoires | Forme Galénique à administration orale pour animaux, son procédé de préparation et ses applications. |
| US5508276A (en) | 1994-07-18 | 1996-04-16 | Eli Lilly And Company | Duloxetine enteric pellets |
| CA2236605A1 (en) | 1997-05-09 | 1998-11-09 | Yves Duccini | Scale inhibitors |
| GB9722426D0 (en) | 1997-10-23 | 1997-12-24 | Univ London Pharmacy | Controlled release formulations |
| GB9724186D0 (en) | 1997-11-14 | 1998-01-14 | British Tech Group | Low temperature coatings |
| US6365185B1 (en) | 1998-03-26 | 2002-04-02 | University Of Cincinnati | Self-destructing, controlled release peroral drug delivery system |
| EP1108431B1 (en) | 1999-12-16 | 2003-05-02 | Laboratorio Medinfar-Produtos Farmaceuticos, S.A. | Gastroresistant multi-unitary pharmaceutical preparations containing piroxicam |
| DE10013029A1 (de) * | 2000-03-17 | 2001-09-20 | Roehm Gmbh | Mehrschichtige Arzneiform für die Colonfreigabe |
| FI20000780L (fi) | 2000-04-03 | 2001-10-04 | Novasso Oy | Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi |
| GB2367002A (en) | 2000-09-25 | 2002-03-27 | British Sugar Plc | Coating composition |
| US20030035839A1 (en) | 2001-05-15 | 2003-02-20 | Peirce Management, Llc | Pharmaceutical composition for both intraoral and oral administration |
| EP1391200A4 (en) * | 2001-05-25 | 2004-06-16 | Ssp Co Ltd | DRUG |
| US7183321B2 (en) * | 2001-12-17 | 2007-02-27 | Bristol-Myers Squibb Company | Antidiabetic formulation and method |
| GB0203421D0 (en) | 2002-02-13 | 2002-04-03 | Alizyme Therapeutics Ltd | Composition |
| US20040028737A1 (en) | 2002-08-12 | 2004-02-12 | Kopran Research Laboratories Limited | Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same |
| JP2006515318A (ja) | 2002-10-29 | 2006-05-25 | ファルマシア・コーポレーション | 特異的に発現する癌関連遺伝子、それによってコードされるポリペプチドおよびその使用方法 |
| US7670627B2 (en) | 2002-12-09 | 2010-03-02 | Salvona Ip Llc | pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients |
| WO2004058228A1 (en) | 2002-12-24 | 2004-07-15 | Lupin Limited | Enteric coated fluoxetine composition |
| GB0403247D0 (en) | 2004-02-13 | 2004-03-17 | Tillotts Pharma Ag | A pharmaceutical composition |
| US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| WO2007034503A2 (en) | 2005-06-20 | 2007-03-29 | Cadila Healthcare Limited | Controlled release dosage formulation of duloxetine |
| DE102005032806A1 (de) * | 2005-07-12 | 2007-01-18 | Röhm Gmbh | Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten |
| GB0607534D0 (en) | 2006-04-13 | 2006-05-24 | Univ London Pharmacy | Colonic drug delivery formulation |
| WO2008020286A2 (en) * | 2006-08-14 | 2008-02-21 | Torrent Pharmaceuticals Limited | Pharmaceutical compositions of duloxetine |
| TW200843802A (en) | 2007-02-09 | 2008-11-16 | Drugtech Corp | Compositions for improving gastrointestinal nutrient and drug absorption |
| JP2008214249A (ja) * | 2007-03-02 | 2008-09-18 | Takeda Chem Ind Ltd | 製剤における溶出改善方法および溶出性の改善された製剤 |
| EP2143424A4 (en) | 2007-03-26 | 2013-07-31 | Teikoku Seiyaku Kk | ORAL PHARMACEUTICAL PREPARATION FOR SPECIFIC DELIVERY TO THE COLON |
| KR101443943B1 (ko) * | 2007-05-07 | 2014-10-07 | 에보니크 룀 게엠베하 | 가속된 약물 방출을 갖는 장용 코팅을 포함하는 고체 투여 형태 |
| US20090162434A1 (en) * | 2007-12-21 | 2009-06-25 | Disphar International Bv | Mesalazine tablet |
| GB0808537D0 (en) | 2008-05-12 | 2008-06-18 | Archimedes Dev Ltd | Compositions |
| US20110177164A1 (en) | 2008-10-06 | 2011-07-21 | Gopal Rajan | Pharmaceutical Compositions Comprising Amorphous Esomeprazole, Dosage Forms And Process Thereof |
| KR102012111B1 (ko) | 2009-06-15 | 2019-08-19 | 아마린 파마, 인크. | 병용 스타틴 요법을 받는 대상체에서 ｌｄｌ－ｃ 수준을 상승시키지 않으면서 트리글리세리드를 저하시키기 위한 조성물 및 방법 |
| DE102009033621A1 (de) | 2009-07-17 | 2011-01-20 | Add Technologies Ltd. | Trennschichten für pharmazeutische Zubereitungen zur Verhinderung von Wechselwirkungen zwischen Arzneistoffen und pharmazeutisch-technologischen Hilfsstoffen |
| JP5827952B2 (ja) | 2009-10-09 | 2015-12-02 | ユンジン・ファーム・カンパニー・リミテッドＹｕｎｇｊｉｎ Ｐｈａｒｍ． Ｃｏ． Ｌｔｄ． | 速効性と持続性を同時に有する薬剤学的組成物 |
| EP2384746A3 (en) * | 2010-05-05 | 2012-03-07 | Sanovel Ilac Sanayi ve Ticaret A.S. | Dual release oral tablet compositions of dexlansoprazole |
| US20130259947A1 (en) | 2010-11-29 | 2013-10-03 | Dr. Reddy's Laboratories Ltd. | Oral metronidazole pharmaceutical compositions |
| WO2013035081A2 (de) | 2011-09-07 | 2013-03-14 | JÄNISCH, Melisa | Optimale formulierung zur freisetzung eines wirkstoffes im dickdarm |
| CN102319218B (zh) | 2011-09-22 | 2014-10-01 | 贝沃特医药技术(上海)有限公司 | 一种治疗肠道疾病的药物缓控释微粒制剂及其制备方法 |
| JOP20200144A1 (ar) | 2012-04-30 | 2017-06-16 | Tillotts Pharma Ag | تركيبة عقار ذو إطلاق متأخر |
| US9844436B2 (en) | 2012-10-26 | 2017-12-19 | Edwards Lifesciences Corporation | Aortic valve and conduit graft implant tool |
-
2013
- 2013-10-29 BR BR122020013726-6A patent/BR122020013726B1/pt active IP Right Grant
- 2013-10-29 TN TN2016000119A patent/TN2016000119A1/en unknown
- 2013-10-29 EA EA201690596A patent/EA032504B1/ru unknown
- 2013-10-29 BR BR112016004863-6A patent/BR112016004863B1/pt not_active IP Right Cessation
- 2013-10-29 EP EP19163986.3A patent/EP3542791A1/en active Pending
- 2013-10-29 MY MYPI2016700483A patent/MY189394A/en unknown
- 2013-10-29 AU AU2013404367A patent/AU2013404367B2/en active Active
- 2013-10-29 UA UAA201605286A patent/UA117260C2/uk unknown
- 2013-10-29 MX MX2019002162A patent/MX388063B/es unknown
- 2013-10-29 NZ NZ747731A patent/NZ747731A/en unknown
- 2013-10-29 CN CN201380079616.6A patent/CN105555260B/zh active Active
- 2013-10-29 MX MX2016001840A patent/MX382146B/es unknown
- 2013-10-29 NZ NZ717159A patent/NZ717159A/en unknown
- 2013-10-29 SG SG11201600501UA patent/SG11201600501UA/en unknown
- 2013-10-29 PH PH1/2020/551522A patent/PH12020551522A1/en unknown
- 2013-10-29 KR KR1020167007738A patent/KR102174942B1/ko active Active
- 2013-10-29 HK HK16110696.8A patent/HK1222547A1/zh unknown
- 2013-10-29 US US15/028,863 patent/US10799515B2/en active Active
- 2013-10-29 JP JP2016526336A patent/JP6273356B2/ja active Active
- 2013-10-29 EP EP13785437.8A patent/EP3062776A1/en active Pending
- 2013-10-29 CN CN201910246206.5A patent/CN110279669B/zh active Active
- 2013-10-29 CA CA2923063A patent/CA2923063C/en active Active
- 2013-10-29 KR KR1020207017564A patent/KR102237356B1/ko active Active
- 2013-10-29 MA MA38847A patent/MA38847B2/fr unknown
- 2013-10-29 WO PCT/EP2013/072648 patent/WO2015062640A1/en not_active Ceased
-
2014
- 2014-10-29 SA SA116370660A patent/SA116370660B1/ar unknown
- 2014-10-29 SA SA114360006A patent/SA114360006B1/ar unknown
- 2014-10-29 TW TW108142795A patent/TWI736031B/zh active
- 2014-10-29 TW TW108122234A patent/TWI725458B/zh active
- 2014-10-29 TW TW103137471A patent/TWI680774B/zh active
-
2016
- 2016-01-28 ZA ZA2016/00630A patent/ZA201600630B/en unknown
- 2016-02-15 PH PH12016500307A patent/PH12016500307B1/en unknown
- 2016-02-23 IL IL244260A patent/IL244260B/en unknown
- 2016-04-25 CR CR20160192A patent/CR20160192A/es unknown
- 2016-04-26 CU CUP2016000055A patent/CU20160055A7/es unknown
-
2019
- 2019-03-14 IL IL265381A patent/IL265381B/en unknown
-
2020
- 2020-02-25 AU AU2020201365A patent/AU2020201365B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA38847B2 (fr) | Formulation médicamenteuse à libération retardée | |
| MX373249B (es) | Formulacion de farmaco de liberacion retardada que comprende un nucleo y un recubrimiento multicapa para el nucleo que comprende al menos tres capas polimericas. | |
| EP3616696A4 (en) | ORAL ENZALUTAMIDE-CONTAINING PHARMACEUTICAL COMPOSITION | |
| RU2015140119A (ru) | Таблетка, покрытая кишечнорастворимым покрытием | |
| PH12018500304B1 (en) | A delayed release drug formulation | |
| WO2014184662A3 (en) | Antiemetic extended release solid dosage forms | |
| SA521422194B1 (ar) | صيغة توصيل عقار قولوني | |
| TH148827A (th) | สูตรผสมยาชนิดปลดปล่อยแบบชะลอ | |
| TH148827B (th) | สูตรผสมยาชนิดปลดปล่อยแบบชะลอ | |
| TH181888A (th) | สูตรผสมยาชนิดปลดปล่อยแบบชะลอ | |
| CU24302B1 (es) | Formulación de fármaco de liberación retardada |